BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32964729)

  • 21. Comparison of the Montreal Cognitive Assessment and the Mini-Mental State Examination in detecting multi-domain mild cognitive impairment in a Chinese sub-sample drawn from a population-based study.
    Dong Y; Yean Lee W; Hilal S; Saini M; Wong TY; Chen CL; Venketasubramanian N; Ikram MK
    Int Psychogeriatr; 2013 Nov; 25(11):1831-8. PubMed ID: 23870281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal cutoff scores for dementia and mild cognitive impairment of the Montreal Cognitive Assessment among elderly and oldest-old Chinese population.
    Tan JP; Li N; Gao J; Wang LN; Zhao YM; Yu BC; Du W; Zhang WJ; Cui LQ; Wang QS; Li JJ; Yang JS; Yu JM; Xia XN; Zhou PY
    J Alzheimers Dis; 2015; 43(4):1403-12. PubMed ID: 25147113
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychometric Evaluation of a Tablet-Based Tool to Detect Mild Cognitive Impairment in Older Adults: Mixed Methods Study.
    McMurray J; Levy A; Pang W; Holyoke P
    J Med Internet Res; 2024 Apr; 26():e56883. PubMed ID: 38640480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing Approaches to Optimize Cut-off Scores for Short Cognitive Screening Instruments in Mild Cognitive Impairment and Dementia.
    O'Caoimh R; Gao Y; Svendovski A; Gallagher P; Eustace J; Molloy DW
    J Alzheimers Dis; 2017; 57(1):123-133. PubMed ID: 28222528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.
    Trzepacz PT; Hochstetler H; Wang S; Walker B; Saykin AJ;
    BMC Geriatr; 2015 Sep; 15():107. PubMed ID: 26346644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Slovenian version of the Montreal Cognitive Assessment Scale as a screening tool for the detection of mild cognitive impairment.
    Špeh A; Kalar I; Pirtošek Z; Kramberger MG
    Acta Neurol Belg; 2024 Apr; 124(2):543-547. PubMed ID: 38436822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Persian Version of the Quick Mild Cognitive Impairment Screen (Q
    Rezaei M; Shariati B; Molloy DW; O'Caoimh R; Rashedi V
    Int J Environ Res Public Health; 2021 Aug; 18(16):. PubMed ID: 34444331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of the Chinese version of Addenbrooke's cognitive examination III for detecting mild cognitive impairment.
    Pan FF; Wang Y; Huang L; Huang Y; Guo QH
    Aging Ment Health; 2022 Feb; 26(2):384-391. PubMed ID: 33533261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Dutch version of the quick mild cognitive impairment screen (Qmci-D).
    Bunt S; O'Caoimh R; Krijnen WP; Molloy DW; Goodijk GP; van der Schans CP; Hobbelen HJ
    BMC Geriatr; 2015 Oct; 15():115. PubMed ID: 26431959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Standardised Mini-Mental State Examination.
    Messinis L; O'Donovan MR; Molloy DW; Mougias A; Nasios G; Papathanasopoulos P; Ntoskou A; O'Caoimh R
    Arch Clin Neuropsychol; 2021 May; 36(4):578-586. PubMed ID: 32783063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of the Spanish-language version of the Montreal Cognitive Assessment as a screening test for cognitive impairment in multiple sclerosis.
    Gomez-Moreno SM; Cuadrado ML; Cruz-Orduña I; Martínez-Acebes EM; Gordo-Mañas R; Fernández-Pérez C; García-Ramos R
    Neurologia (Engl Ed); 2022; 37(9):726-734. PubMed ID: 34836843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson's disease.
    Badrkhahan SZ; Sikaroodi H; Sharifi F; Kouti L; Noroozian M
    Appl Neuropsychol Adult; 2020; 27(5):431-439. PubMed ID: 30821505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Cuban Version of Addenbrooke's Cognitive Examination-Revised for Screening Mild Cognitive Impairment.
    Broche-Pérez Y; López-Pujol HA
    Dement Geriatr Cogn Disord; 2017; 44(5-6):320-327. PubMed ID: 29393151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
    Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
    Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of the Sinhala Version of the Addenbrooke's Cognitive Examination-Revised for the Detection of Dementia in Sri Lanka: Comparison with the Mini-Mental Status Examination and the Montreal Cognitive Assessment.
    Suriyakumara V; Srikanth S; Wijeyekoon R; Gunasekara H; Muthukuda C; Rajapaksha D; Weerasekara R; Gonawala L; Wijekoon N; de Silva KRD
    Dement Geriatr Cogn Disord; 2019; 47(4-6):198-208. PubMed ID: 31311022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of--or as well as--the MMSE?
    Larner AJ
    Int Psychogeriatr; 2012 Mar; 24(3):391-6. PubMed ID: 22014176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of the Polish versions of the Montreal Cognitive Assessment 7.2 and the Mini-Mental State Examination as screening instruments for the detection of mild neurocognitive disorder.
    Sokołowska N; Sokołowski R; Oleksy E; Kasperska P; Klimkiewicz-Wszelaki K; Polak-Szabela A; Podhorecka M; Kędziora-Kornatowska K
    Neurol Neurochir Pol; 2020; 54(5):440-448. PubMed ID: 32808669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MoCA 7.1: Multicenter Validation of the First Italian Version of Montreal Cognitive Assessment.
    Pirani A; Nasreddine Z; Neviani F; Fabbo A; Rocchi MB; Bertolotti M; Tulipani C; Galassi M; Belvederi Murri M; Neri M
    J Alzheimers Dis Rep; 2022; 6(1):509-520. PubMed ID: 36186724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Addenbrooke's cognitive examination III for detecting mild cognitive impairment and dementia in Japan.
    Takenoshita S; Terada S; Yoshida H; Yamaguchi M; Yabe M; Imai N; Horiuchi M; Miki T; Yokota O; Yamada N
    BMC Geriatr; 2019 Apr; 19(1):123. PubMed ID: 31035933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.